Bioreactors and Fermenters Market by Global Type & Application 2016 - 2024

Global Bioreactors and Fermenters Market: Overview

Bioreactors and fermenters facilitate the growth of microorganisms or biochemically active substances and are widely used in the biopharmaceutical industry for the production of monoclonal recombinant proteins, antibodies, and vaccines at a large scale. Advancements in the technology pertaining to bioprocessing have significantly increased the expression yield due to progress in expression systems, cell lines, and cultures and have, therefore, rendered large scale bio-manufacturing processes feasible. Hence, technological advancements are revolutionizing the global bioreactors and fermenters market.

Bioreactors and fermenters are used by contract research organizations (CROs), academic and research institutes, and biopharmaceutical companies. They primarily depend on three modes of operations, which are continuous, batch, and fed-batch. The adoption rate of continuous mode is likely to remain high throughout the forecast period due to its benefits such as higher productivity and reduction in operation costs.

The research report is a professional study extensively covering all the important parameters, such as geographical segmentation, trends and opportunities, and competitive scenario of the global bioreactors and fermenters market. It profiles prominent participants in the global market along with their business strategies, latest developments, and product offerings.

Obtain Report Details @
http://www.transparencymarketresearch.com/bioreactors-fermenters-market.html

Global Bioreactors and Fermenters Market: Drivers and Restraints

The increasing implementation of hybrid technologies is stoking the growth of the global bioreactors and fermenters market. The growing adoption of single-use disposable bioreactors across the biopharmaceutical sector is also working in favor of the market. Single-use bioreactors find widespread application in clinical areas. Moreover, the rising incidence of chronic diseases is stirring up the demand for biologics. This along with the soaring demand for personalized medicines and orphan drugs is augmenting the market. On the flip side, the high cost of installation of bioreactors and fermenters is restricting the market from realizing its utmost potential. In addition, the rising concerns regarding leachable and extractable are inhibiting the growth of the global market.

Global Bioreactors and Fermenters Market: Geographical Segmentation

North America was the leading regional market for bioreactors and fermenters in 2015. The dominance of the region can be attributed to a couple of factors, including advancements in bioprocessing systems and spiraling demand for single-use disposable bioreactors. Key bioprocessing equipment manufacturers are headquartered in the region, which provides it an edge over other regions. North America is closely trailed by Europe. The growth of Europe can be attributed to the burgeoning demand for biologics and orphan drugs.

Asia Pacific, on the other hand, is expected to be the most promising region during the forecast period. The growing investments by biopharmaceutical companies and contract manufacturers in emerging countries such as China, India, and Korea are fuelling the growth of the region. Besides this, the rising prevalence of chronic diseases and the increasing initiatives by governments to immunize their population are promoting the deployment of bioreactors and fermenters in APAC. The growth conditions of Latin America and the Middle East and Africa are quite similar to that of Asia Pacific and therefore, these regions are poised to witness noteworthy growth in coming years.

Global Bioreactors and Fermenters Market: Competitive Landscape

Some of the prominent companies operating in the global bioreactors and fermenters market are Danaher Corporation, Applikon Biotechnology B.V., Finesse Solutions Inc, Eppendorf AG, Merck KGaA, GE Healthcare, Pierre Guerin Technologies, PBS Biotech Inc., Sartorius AG, Thermo Fisher Scientific Inc., Solaris Biotechnology, and ZETA Holding GmbH. The majority of key players are banking on strategies such as mergers and acquisitions and collaborations to consolidate their presence in the market.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15230

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

This release was published on openPR.